Innovotech Inc. (CVE:IOT – Get Free Report)’s stock price was up 25% on Wednesday. The company traded as high as C$0.07 and last traded at C$0.07. Approximately 163,000 shares were traded during trading, an increase of 249% from the average session volume of 46,647 shares. The stock had previously closed at C$0.06.
Innovotech Price Performance
The company has a debt-to-equity ratio of 12.55, a quick ratio of 5.81 and a current ratio of 2.63. The company has a market capitalization of C$4.08 million, a PE ratio of -5.35 and a beta of 3.12. The company’s 50-day simple moving average is C$0.07 and its 200-day simple moving average is C$0.13.
Innovotech Company Profile
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.
Read More
- Five stocks we like better than Innovotech
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
- Why Apple Stock Looks Like a Safe Haven After the Midterms
- IonQ Raised the Bar, But 3 Quantum Rivals Face Tough Questions
Receive News & Ratings for Innovotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovotech and related companies with MarketBeat.com's FREE daily email newsletter.
